Study for bladder pain using a nerve-based treatment (EA)
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a nerve-based therapy called EA can reduce bladder pain. It also aims to understand why the treatment may help by looking at underlying mechanisms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old, and you can take part if you are male or female.
- You meet the trial’s bladder pain diagnosis standards (both diagnostic criteria).
- Your bladder pain score (VAS) is between 30 and 80 millimeters.
- You can understand the study steps and agree in writing to join.
- You have not recently joined another clinical study (within the last 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans (fMRI) to learn how bladder pain syndrome affects the brain. It compares women with bladder pain to those without, to better understand symptoms and improve future treatments.
This trial tests a new nerve stimulation approach for women with bladder pain syndrome. It aims to find a gentler way to reduce pain and urgency without surgery.
This trial tests whether acupuncture can help relieve pain and pressure from bladder pain syndrome (also called interstitial cystitis). Researchers want to see if using acupuncture early can improve symptoms better than usual care.
This trial tests a combination of a medication called pregabalin with education and behavioral counseling to see if it improves bladder pain and urgent, frequent urination in people with bladder pain syndrome/interstitial cystitis (a condition causing long-term bladder pain and urinary symptoms).
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.
Hear when a new Bladder Pain Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.